Kilitch Drugs (India) consolidated net profit rises 126.12% in the June 2025 quarter
Sales rise 28.97% to Rs 43.14 crore
Net profit of Kilitch Drugs (India) rose 126.12% to Rs 3.03 crore in the quarter ended June 2025 as against Rs 1.34 crore during the previous quarter ended June 2024. Sales rose 28.97% to Rs 43.14 crore in the quarter ended June 2025 as against Rs 33.45 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var.Sales43.1433.45 29 OPM %7.564.96 -PBDT4.292.50 72 PBT3.451.65 109 NP3.031.34 126Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content